Ledger.Open graph →
SEC Form D · filed September 13, 2019

Cidara Therapeutics, Inc

Offering
$9.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Robert Levine · FARMINGTON HILLS, MIExecJessica R. Oien · San Diego, CAExecThomas L. Croft · DARTMOUTH, Nova Scotia, CanadaDirectorJames R. Levine · San Diego, CAExecMichael D. Weiss · New York City, NYDirectorRobert L. Whitham · Shenandoah, IAExecPaul Feldman · Boston, MADirectorKim Bishop · Grand Cayman, Cayman IslandsDirectorIan Charles · FARMINGTON HILLS, MIDirectorCorey M. Steffek · Boston, MAExec · DirectorGino Santini · Boston, MAExecMarc Lehmann · Miami Beach, FLExecPepe Zevada · AUSTIN, TXExecDavid R. Gollaher · San Diego, CADirectorCameron W. Mcrae · Dartmouth, Nova Scotia, CanadaDirectorKeith Crandell · Boston, MAExec · DirectorAndrew Funk · Denver, COExecThane Wettig · Boston, MADirectorKurt Graves · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗